Charles M. Fernandez - 01 Jul 2023 Form 4 Insider Report for Progressive Care Inc.

Reporting relationship: Chairman & CEO, Director, 10%+ Owner
Issuer ticker: N/A
Reported as of: 01 Jul 2023
Net transaction value: +$506,001
SEC form: 4
Accepted by SEC: 20 Oct 2023, 12:04:51 UTC
Prior SEC filing: 30 Jun 2023
Next SEC filing: 23 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/ Charles M. Fernandez

Key filing fact

Charles M. Fernandez filed Form 4 for Progressive Care Inc. on 20 Oct 2023.

Key facts

This page summarizes Charles M. Fernandez's Form 4 filing for Progressive Care Inc..
14 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 20 Oct 2023, 12:04.

Change

Previous filing in this sequence was filed on 30 Jun 2023.
Current net transaction value: +$506,001.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RXMD transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $502,128
Shares: +228,240
Change %: +17%
Price: $2.20
Shares after: 1,557,356
Date: 01 Jul 2023
Ownership: By eAperion Partners LLC
Footnotes: F7, F8

RXMD transaction

Common Stock

Sale

Transaction value: $502,129
Shares: -112,838
Change %: -7.2%
Price: $4.45
Shares after: 1,444,518
Date: 01 Jul 2023
Ownership: By eAperion Partners LLC
Footnotes: F1, F7

RXMD transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $418,000
Shares: +190,000
Change %: +13%
Price: $2.20
Shares after: 1,634,518
Date: 01 Jul 2023
Ownership: By eAperion Partners LLC
Footnotes: F7

RXMD transaction

Common Stock

Sale

Transaction value: $417,997
Shares: -93,932
Change %: -5.7%
Price: $4.45
Shares after: 1,540,586
Date: 01 Jul 2023
Ownership: By eAperion Partners LLC
Footnotes: F2, F7

RXMD transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $1,001,000
Shares: +455,000
Change %: +30%
Price: $2.20
Shares after: 1,995,586
Date: 01 Jul 2023
Ownership: By NextPlat Corp
Footnotes: F6

RXMD transaction

Common Stock

Sale

Transaction value: $1,001,001
Shares: -224,944
Change %: -11%
Price: $4.45
Shares after: 1,770,642
Date: 01 Jul 2023
Ownership: By NextPlat Corp
Footnotes: F3, F6

RXMD transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $749,318
Shares: +340,599
Change %: +19%
Price: $2.20
Shares after: 2,111,241
Date: 01 Jul 2023
Ownership: By NextPlat Corp
Footnotes: F6

RXMD transaction

Common Stock

Sale

Transaction value: $749,318
Shares: -168,386
Change %: -8%
Price: $4.45
Shares after: 1,942,855
Date: 01 Jul 2023
Ownership: By NextPlat Corp
Footnotes: F4, F6

RXMD transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $506,000
Shares: +230,000
Change %: +12%
Price: $2.20
Shares after: 2,172,855
Date: 01 Jul 2023
Ownership: By NextPlat Corp
Footnotes: F5, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RXMD transaction Derivative

Common Stock Warrant

Exercise of in-the-money or at-the-money derivative security

Transaction value: $0
Shares: +228,240
Change %
Price: $0.000000^*
Shares after: 0
Date: 01 Jul 2023
Ownership: By eAperion Partners LLC
Underlying class: Common Stock
Underlying amount: 228,240
Exercise price: $2.20
Footnotes: F7

RXMD transaction Derivative

Common Stock Warrant

Exercise of in-the-money or at-the-money derivative security

Transaction value: $0
Shares: +190,000
Change %
Price: $0.000000^*
Shares after: 0
Date: 01 Jul 2023
Ownership: By eAperion Partners LLC
Underlying class: Common Stock
Underlying amount: 190,000
Exercise price: $2.20
Footnotes: F7

RXMD transaction Derivative

Common Stock Warrant

Exercise of in-the-money or at-the-money derivative security

Transaction value: $0
Shares: +455,000
Change %
Price: $0.000000^*
Shares after: 0
Date: 01 Jul 2023
Ownership: By NextPlat Corp
Underlying class: Common Stock
Underlying amount: 455,000
Exercise price: $2.20
Footnotes: F6

RXMD transaction Derivative

Common Stock Warrant

Exercise of in-the-money or at-the-money derivative security

Transaction value: $0
Shares: +340,599
Change %
Price: $0.000000^*
Shares after: 0
Date: 01 Jul 2023
Ownership: By NextPlat Corp
Underlying class: Common Stock
Underlying amount: 340,599
Exercise price: $2.20
Footnotes: F6

RXMD transaction Derivative

Common Stock Warrant

Exercise of in-the-money or at-the-money derivative security

Transaction value: $0
Shares: +230,000
Change %
Price: $0.000000^*
Shares after: 0
Date: 01 Jul 2023
Ownership: By NextPlat Corp
Underlying class: Common Stock
Underlying amount: 230,000
Exercise price: $2.20
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

On July 1, 2023, eAperion Partners, LLC exercised a Conversion Warrant to purchase 228,240 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 112,838 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 115,402 shares.

Footnote F2

On July 1, 2023, eAperion Partners, LLC exercised an Inducement Warrant to purchase 190,000 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 93,932 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 96,068 shares.

Footnote F3

On July 1, 2023, NextPlat Corp exercised a Warrant to purchase 455,000 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 224,944 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 230,056 shares.

Footnote F4

On July 1, 2023, NextPlat Corp exercised a Conversion Warrant to purchase 340,599 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 168,386 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 172,213 shares.

Footnote F5

On July 1, 2023, NextPlat Corp, exercised a Conversion Warrant to purchase 230,000 shares of RXMD common stock for $2.20 per share. NextPlat Corp paid the exercise price on a cash basis.

Footnote F6

The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Footnote F7

The Reporting Person is the sole member and managing member of eAperion Partners LLC.

Footnote F8

Includes 18,261 shares of common stock directly held by the Reporting Person; 1,071,251 shares of common stock held indirectly by NextPlat Corp., of which the Reporting Person is the Chief Executive Officer; and 239,604 shares of common stock held indirectly by eAperion Partners LLC, of which the Reporting person is the sole member and managing member.